Last news

IntegraGen presents autism research at IMFAR

IntegraGen announced today the presentation scientific data which demonstrates the role of common genetic variants towards the identificaiton of risk of autism in siblings of children diagnosed with autism spectrum disorders during the 2012 International Meeting for Autism Research. 



Annual Results 2011

IntegraGen announced today financial results for the year ending December 31, 2011. 

Home

IntegraGen’s vocation is firstly to establish the link between innovations derived from molecular research and medical practise, by developing biomarkers for autism and oncology specifically intended for clinical use, and subsequently to make its genomics services available to practitioners and researchers thanks to its exceptional technological and scientific know-how.

With the support of its network of partners and experts, IntegraGen is now well established as one of the leaders in its sector.